MASLD
-
healthDutch Liver Cancer Cases Rise Sharply, Driven by Metabolic Disease
A new study shows hepatocellular carcinoma incidence in the Netherlands increased from 2014 to 2022, with the steepest rise linked to metabolic dysfunction-associated steatotic liver disease (MASLD).
-
healthAlcohol-Related Liver Disease Carries Greatest Dementia Risk, Study Finds
A nationwide study of over 3 million adults found steatotic liver disease associated with dementia, with alcohol-related liver disease posing the greatest risk, even as alcohol consumption patterns modify outcomes.
-
healthMASLD Redefined: Expert Insights on Multisystem Liver Disease and Future Therapies
Sven Francque discusses the paradigm shift in MASLD treatment at EASL 2026, emphasizing multisystem care, diagnostic gaps, and the future of combination therapies for metabolic liver disease.
-
healthEASL 2026: Rethinking MASLD as a Multisystem Disorder
Sven Francque discusses the paradigm shift in MASLD treatment, emphasizing multisystem care, diagnostic gaps, and individualized pharmacological strategies at EASL 2026.
-
healthThe Silent Threat: What Women Need to Know About Liver Disease
Liver disease affects millions of US adults, with women at higher risk. Understand causes, symptoms, and stages.
-
healthThe Silent Threat: Understanding Liver Disease in Women
Learn about chronic liver disease, its stages, symptoms, and causes, with a focus on risks for women.
-
healthKetogenic Diet Dramatically Slashes Liver Fat in MASLD Patients
A very low-energy ketogenic diet significantly reduced liver fat by 77% in MASLD patients, far surpassing a Mediterranean diet in a pilot study.
-
healthBinge Drinking Once Monthly Triples Liver Fibrosis Risk in MASLD Patients
New US study reveals that episodic heavy drinking significantly elevates liver fibrosis risk for individuals with metabolic dysfunction-associated steatotic liver disease.